Paul Lietman, MD, PhD
and Pediatrics, and Pharmacology and Molecular Sciences
Johns Hopkins University
School of Medicine, Department of Medicine
1830 E. Monument Street, Suite 7100
Baltimore, MD 21287
Clinical pharmacology of antibacterial and antiviral drugs, development of complementary and alternative medicines, and ethics of human experimentation
Lewis, LD, Amin S, Civin CI, Lietman PS (2004). Ex vivo zidovudine (AZT) treatment of CD34 / bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production. Human Exptl Tox Apr;23:173-185.
Lee LS, Wise SD, Chan C, Parsons TL, Flexner C, Lietman PS (2008). Possible Differential Induction of Phase 2 Enzyme and Antioxidant Pathways by American Ginseng, Panax quinquefolius. J Clin Pharmacol; 48:599-609
Lee LS, Stephenson K, Fahey JW, Parsons, TL, Lietman PS, Andrade AS, Xiaoguang L, Heedong Y, Gaik HS, Shen P, Danishefsky S, Flexner C. Induction of chemoprotective phase 2 enzymes by ginseng and its components. Planta Medica. Submitted.
Lietman PS Commentary on the Declaration of Helsinki "Ethical Principles for Research Involving Human Subjects". (2009) Clinical Trial Magnifier. (2):52-55.
Meyerhoff, A and Lietman PS "All the World's a Laboratory" The New York Times, May 10th, 2009.